These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14377785)

  • 1. [Clinical and experimental study of the association of ammonium camphorsulfonate and quinine hydrobromide].
    ROSSANDA M
    Arch Farmacol Sper Sci Affin; 1953; 81(5-6):128-31. PubMed ID: 14377785
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic use of ammonium camphorsulfonate combined with quinine hydrobromic acid].
    FONTANINI F
    Riforma Med; 1956 Nov; 70(45):1295-7. PubMed ID: 13390535
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combination of ammonium camphorsulfonic acid and quinine bromhydrate in therapy].
    INTROZZI P
    Riforma Med; 1957 Feb; 71(5):128-9. PubMed ID: 13421389
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin neutralization: experimental and clinical studies.
    Castaneda AR; Gans H; Weber KC; Fox IJ
    Surgery; 1967 Oct; 62(4):686-97. PubMed ID: 6051112
    [No Abstract]   [Full Text] [Related]  

  • 5. [Control of changes in emotional tension by the heart].
    Santana ET; Sabbag M; Seixas A; Tashima F; Marchiotto O; Yamagichi N; Santana MA
    Hospital (Rio J); 1968 Nov; 74(5):1695-700. PubMed ID: 5305346
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental study and clinical use of etonium].
    Pis'ko GT; Vasiliuk VN
    Vrach Delo; 1989 May; (5):94-7. PubMed ID: 2672588
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined comphosulfonate of ammonium and hydrobromate of quinine as cardiovascular function].
    RICCI GC; BILLERI I
    Gazz Med Ital; 1954 Aug; 113(8):242-9. PubMed ID: 13210620
    [No Abstract]   [Full Text] [Related]  

  • 8. One tablet dyspepsia study--pro-banthine.
    McMillin WP
    J R Coll Gen Pract; 1969 May; 17(82):329-30. PubMed ID: 4388914
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of methantheline hydrobromide on normal and pathological bladder function; its value in sphincteral disorders of neurological origin].
    PESTEL M
    Presse Med (1893); 1953 Jun; 61(41):851-2. PubMed ID: 13088735
    [No Abstract]   [Full Text] [Related]  

  • 10. [Denoral (F.F. 65) in child otorhinolaryngology (clinical experimentation)].
    Berger M; Quichaud
    Rev Laryngol Otol Rhinol (Bord); 1968; 89(1):131-4. PubMed ID: 5754673
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experience with myxal].
    FUCHS HK; HAACK K
    Dtsch Med Wochenschr; 1955 Mar; 80(11):374-6. PubMed ID: 14365349
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary clinical experience with a new hemostatic: dicyone].
    Del Prete S; Fruttero F
    Minerva Otorinolaringol; 1967; 17(3):73-5. PubMed ID: 5606754
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quaternary ammonium compounds in therapy].
    CHAIGNEAU M
    Prod Pharm; 1955 May; 10(5):299-308. PubMed ID: 14395319
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anisotropine methylbromide (Valpin) in the treatment of spasms of the gastrointestinal system. Biometric study].
    Giovannelli CA; Vigo PL
    Minerva Med; 1970 Dec; 61(102):5942-51. PubMed ID: 5498741
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of dermatoses with dermofongin preparations].
    SCHULTZE W
    Dtsch Med Wochenschr; 1955 Jan; 80(1):27-30. PubMed ID: 14352743
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myko-Calmitol in infectious skin diseases].
    Kurz JF
    Z Allgemeinmed; 1970 Jul; 46(19):1001-4. PubMed ID: 5522817
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of antiarrhythmic activity and duration of action of quaternidine].
    Moiseeva IIa; Blinov DS; Kostin IaV
    Eksp Klin Farmakol; 2003; 66(5):22-4. PubMed ID: 14650209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with the use of sulfur derivatives in local therapy of skin diseases].
    Lebedev BM
    Vestn Dermatol Venerol; 1965 Jun; 39(6):32-5. PubMed ID: 5859148
    [No Abstract]   [Full Text] [Related]  

  • 19. [DDKhA preparation--an effective means in the treatment of animals].
    Ter-Pogosov SP
    Veterinariia; 1969 May; 5():60-1. PubMed ID: 5393442
    [No Abstract]   [Full Text] [Related]  

  • 20. A CCR-5 antagonist inhibits the development of adjuvant arthritis in rats.
    Okamoto H; Kamatani N
    Rheumatology (Oxford); 2006 Feb; 45(2):230-2. PubMed ID: 16319100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.